Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
viernes, octubre 30
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Amgen Inc
AMGN
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$469.97
9.24
2.01%
Últ. Act.: Oct 30, 10:23 AM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 4 días de ahora en mar nov 3rd, después del cierre del mercado
Conferencia telefónica:
Conferencia telefónica programada para dentro de 4 días a las 4:30 p. m.
Haz clic para ver el webcast
Amgen Financials
Amgen (AMGN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Amgen Narrows FY2026 GAAP EPS Guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 Est
Amgen (NASDAQ:AMGN) narrows FY2026 GAAP EPS guidance from $15.62-$17.10 to $15.80-$17.08 vs $15.44 analyst estimate..
Benzinga Newsdesk
PRO
Amgen Raises FY2026 Adj EPS Guidance from $21.70-$23.10 to $22.30-$23.50 vs $22.35 Est; Raises FY2026 Sales Guidance from $37.100B-$38.500B to $38.200B-$39.400B vs $37.741B Est
Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.70-$23.10 to $22.30-$23.50 vs $22.35 analyst estimate. Raises FY2026 sales outlook from $37.100 billion-$38.500 billion to $38.200 billion-$39.400 billion vs
Benzinga Newsdesk
PRO
Amgen Q2 Adj. EPS $6.29 Beats $5.62 Estimate, Sales $10.054B Beat $9.421B Estimate
Amgen (NASDAQ:AMGN) reported quarterly earnings of $6.29 per share which beat the analyst consensus estimate of $5.62 by 11.92 percent. This is a 4.49 percent increase over earnings of $6.02 per share from the same
Benzinga Newsdesk
PRO
Update: Amgen Raises FY2026 Adj EPS Guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 Est; Raises FY2026 Sales Guidance from $37.000B-$38.400B to $37.100B-$38.500B vs $37.807B Est
Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 analyst estimate. Raises FY2026 sales outlook from $37.000 billion-$38.400 billion to $37.100 billion-$38.500 billion vs
Benzinga Newsdesk
PRO
Amgen Raises FY2026 Adj EPS Guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 Est
Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 analyst estimate..
Benzinga Newsdesk
PRO
Amgen Raises FY2026 GAAP EPS Guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 Est
Amgen (NASDAQ:AMGN) raises FY2026 GAAP EPS guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 analyst estimate..
Benzinga Newsdesk
